Organic Mineral Microparticles for Uniform Vaccine Adjuvant Binding

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing mineral adjuvants like aluminum hydroxide and calcium phosphate are time-consuming and costly, lack control over particle size homogeneity, and do not optimize antigen binding properties, which affects the efficacy of vaccines.

Innovation Solution

A substitution reaction using organic polyphosphates with specific organic substituents modifies the surface of mineral micro-particles, enhancing electrostatic potential, reducing particle size, and improving antigen binding capacity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional methods are used to produce mineral adjuvants, then production is achieved, but the process is time-consuming and costly

Engineering Contradiction:
Improveproduction efficiencyVSAvoidproduction time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The invention changes the chemical parameters of the adjuvant system by using organically modified mineral particles instead of conventional aluminum salts. This modification alters the surface properties and dissolution kinetics, enabling faster antigen release and reduced manufacturing time while maintaining adjuvant efficacy.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates composite mineral particles by combining inorganic mineral cores (calcium phosphate, aluminum hydroxide) with organic surface modifications. This composite structure provides both the stability of mineral adjuvants and the controlled release properties of organic materials, improving production efficiency.

Inventive Principle:
Principle #40Composite materials

2Manufacturing precision

If conventional mineral adjuvants are used, then antigen binding is achieved, but control over particle size homogeneity is lacking

Engineering Contradiction:
Improveparticle size homogeneityVSAvoidcontrol mechanism complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The invention controls particle size homogeneity by adjusting synthesis parameters such as pH, temperature, and precursor ratios during the formation of mineral particles. The organic modification step further refines size distribution by controlling nucleation and growth rates, achieving uniform particles without complex additional equipment.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If antigen adsorption is increased, then immune response is enhanced, but thermal stability may be compromised

Engineering Contradiction:
Improveimmune response efficacyVSAvoidthermal stability
Core Design Contradiction:
ReliabilityVSTemperature

Solution Approach 1:

The composite structure combines thermally stable mineral cores with organically modified surfaces that provide controlled antigen binding. The mineral core maintains structural integrity at elevated temperatures during sterilization, while the organic surface layer provides sufficient antigen adsorption capacity for effective immune response.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The invention applies different properties to different parts of the adjuvant system: the mineral core provides thermal stability and structural integrity, while the organic surface modification provides enhanced antigen binding and controlled release. This local differentiation of properties resolves the contradiction between thermal stability and antigen adsorption capacity.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The modified mineral micro-particles exhibit higher thermal stability, increased antigen adsorption capacity, and improved immune response induction, making them more effective vaccine adjuvants.

Implementation Method 1

a substitution reaction, or ligand exchange, of hydroxide or orthophosphate groups by organic polyphosphate ions at the surface of said mineral micro-particles

Methodology Applied
Scientific EffectSubstitution reaction: Chemical Bonding

Implementation Method 2

The amount or load of antigen adsorbed by the adjuvant (expressed as weight to weight ratio) is one important parameter

Methodology Applied
Scientific EffectAdsorption: Adsorption

Implementation Method 3

a substitution reaction, or ligand exchange, of hydroxide or orthophosphate groups by organic polyphosphate ions at the surface of said mineral micro-particles

Methodology Applied
Scientific EffectLigand exchange: Ion Exchange

Data Source

PatentUS12569555B2Organically modified mineral micro-particles, methods of preparing the same and uses thereof
Publication Date: 2026.03.10 CRODA INT PLC
  • US12569555B2 patent drawing
  • US12569555B2 patent drawing
  • US12569555B2 patent drawing

AI summary

The present invention is situated in the field of mineral micro-particles selected from the list consisting of aluminum hydroxide, aluminum phosphate, amorphous aluminium hydroxyphosphate and calcium phosphate micro-particles. More particularly, the invention provides organically-derivatized mineral micro-particles, uses thereof, and methods of preparing the same.